BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9577175)

  • 1. [Priority of using conventional cytogenetics, in situ hybridization and PCR in the study of hematologic neoplasms].
    Solé F; Espinet B; Woessner S
    Sangre (Barc); 1998 Feb; 43(1):3-5. PubMed ID: 9577175
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of immunoglobulin heavy chain gene rearrangements in hematologic malignancies.
    Gleissner B; Thiel E
    Expert Rev Mol Diagn; 2001 Jul; 1(2):191-200. PubMed ID: 11901814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In situ hybridization techniques. Basis and applications in hematologic neoplasias].
    Espinet B; Lloveras E; Solé F
    Sangre (Barc); 1999 Aug; 44(4):261-7. PubMed ID: 10589277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Minimal residual disease in hematology].
    Rák K
    Orv Hetil; 2001 May; 142(21):1091-5. PubMed ID: 11449837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular diagnostic tests in hematologic diseases].
    Tohda S; Nara N
    Rinsho Byori; 2001 Mar; 49(3):205-9. PubMed ID: 11307316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetics in the study of malignant blood diseases].
    García JL; Hernández JM; Gutiérrez NC; Fernández P; Ríos A
    Sangre (Barc); 1996 Aug; 41(4):289-95. PubMed ID: 8984670
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytogenetics, in situ hybridization and molecular approaches in the diagnosis of cancer.
    Glassman AB
    Ann Clin Lab Sci; 1998; 28(6):324-30. PubMed ID: 9846199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular biology in malignant blood diseases. Methodological aspects: Southern blotting techniques and the polymerase chain reaction].
    González M; García Sanz R; Chillon MC; Balanzategui A; Vargas M; García MF; San Miguel JF
    Sangre (Barc); 1996 Aug; 41(4):311-9. PubMed ID: 8984673
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essentials of conventional and molecular cytogenetics: application to diagnosis of hematological malignancies].
    Lafage-Pochitaloff M
    Pathol Biol (Paris); 2003 Aug; 51(6):307-11. PubMed ID: 12927887
    [No Abstract]   [Full Text] [Related]  

  • 10. [Applications of fluorescence in situ hybridization in the study of hematologic neoplasms].
    Hernández JM; Tabernero MD; García JL
    Sangre (Barc); 1996 Aug; 41(4):305-9. PubMed ID: 8984672
    [No Abstract]   [Full Text] [Related]  

  • 11. Metaphase FISH, microdissection, and multicolour FISH. Applications in haematology.
    Mecucci C; Falzetti D; La Starza R
    Haematologica; 1999 Jun; 84 Suppl EHA-4():98-101. PubMed ID: 10907483
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chromosomal analysis, fluorescence in situ hybridization method, and spectral karyotyping in hematologic malignancies].
    Nara N
    Rinsho Byori; 2003 Jun; Suppl 126():124-30. PubMed ID: 12905952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytogenetics of malignant hemopathies: update].
    Lai JL; Genevière F; Zandecki M
    Bull Cancer; 1999 Jan; 86(1):23-8. PubMed ID: 10029700
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular cytogenetics.
    Kearney L
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.
    Martín-Subero JI; Gesk S; Harder L; Grote W; Siebert R
    Anticancer Res; 2003; 23(2A):1139-48. PubMed ID: 12820362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicolor FISH.
    Jalal SM; Law ME
    Methods Mol Biol; 2002; 204():105-20. PubMed ID: 12397793
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytogenetics and molecular genetics of hematological malignancy].
    Izutsu K
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():304-8. PubMed ID: 17474424
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
    Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
    Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined strategy of conventional cytogenetics, fluorescent in situ hybridization and microsatellite polymerase chain reaction to analyze the deletion of chromosome 6 in laryngeal squamous cell carcinoma.
    Kang N; Li F; Fu W; Zhang J; Sun K
    Oncol Rep; 2007 Dec; 18(6):1379-85. PubMed ID: 17982620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative genomic hybridization. Methodologic features].
    García JL; Gutiérrez NC; Hernández JM; Sánchez MA; González MB; Arroyo JL; San Miguel JF
    Sangre (Barc); 1999 Aug; 44(4):291-6. PubMed ID: 10589281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.